Skip to main content
Log in

Effects of the beta2-adrenoceptor agonists fenoterol and salbutamol on force of contraction in isolated human ventricular myocardium

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

The effects of fenoterol and salbutamol on isometric force of contraction were studied in isolated, electrically driven human papillary muscle preparations. Fenoterol increased force of contraction at concentrations of 1 µmol l−1 and higher. The maximally effective concentration of fenoterol (100 µmol l−1) increased force of contraction by about 130%. The positive inotropic effect of fenoterol was not influenced by 0.1 µmol l−1 prazosin. The beta1-selective antagonist atenolol (2 µmol l−1) and the beta2-selective antagonist ICI 118551 (1 µmol l−1) shifted the concentration-response curve of fenoterol to the right, indicating that beta1- and beta2-adrenoceptors may contribute to the positive inotropic effect of fenoterol. In contrast to fenoterol, salbutamol increased force of contraction only by about 11% at 100 µmol l−1. The results indicate that: (1) fenoterol exerts a direct positive inotropic effect in the human heart which may support the beneficial effects of the reduction of systemic vascular resistance in patients with congestive heart failure; (2) this positive inotropic effect of fenoterol is mediated by beta1- and beta2-adrenoceptors; (3) the clinically observed improvement of cardiac performance in the case of salbutamol is presumably not due to any direct positive inotropic effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

mN:

millinewton

EC50 :

half maximal effective concentration

SEM:

standard error of the mean

References

  • Aggestrup S, Henriksen L, Rygg IH, Lauridsen P (1980) The cardiovascular and respiratory effects of fenoterol in patients after open-heart surgery. J Cardiovasc Surg 21:409–416

    Google Scholar 

  • Barret AM (1977) The pharmacology of atenolol. Postgrad Med J 53 (Suppl 3):58–64

    PubMed  Google Scholar 

  • Bilski A, Dorries S, Fitzgerald JD, Jessup R, Tucker H, Wale J (1980) ICI 118551 a potent β2-adrenoceptor antagonist. Br J Pharmacol 69:292P-293P

    Google Scholar 

  • Bilski A, Halliday SE, Fitzgerald JD, Wale JL (1983) The pharmacology of a beta2-selective adrenoceptor antagonist (ICI 118551). J Cardiovasc Pharmacol 5:430–437

    PubMed  Google Scholar 

  • Bourdillon PDV, Dawson JR, Foale RA, Timmis AD, Poole-Wilson PA, Sutton GC (1980) Salbutamol in treatment of heart failure. Br Heart J 43:206–210

    PubMed  Google Scholar 

  • Brittain RT (1971) A comparison of the pharmacology of salbutamol with that of isoprenaline, orciprenaline and trimetoquinol. Postgrad Med J 47 (Suppl): 11–16

    Google Scholar 

  • Brodde OE, Karad K, Zerkowski HR, Rohm N, Reidemeister JC (1983) Coexistence of β1- and β2-adrenoceptors in human right atrium. Direct indentification by (±)-(125J)iodocyanopindolol binding. Circ Res 53:752–758

    PubMed  Google Scholar 

  • Brown JE, McLeod AA, Shand DG (1983) Evidence for cardiac 31-3-adrenoceptors in man. J Clin Pharmacol Ther 33:424–428

    Google Scholar 

  • Brückner R, Meyer W, Mügge A, Schmitz W, Scholz H (1984) Alpha-adrenoceptor-mediated positive inotropic effect of phenylephrine in isolated human ventricular myocardium. Eur J Pharmacol 99:345–347

    PubMed  Google Scholar 

  • Buchelt L, Rominger KL (1972) Pharmakokinetic und Metabolismus von Th 1165 A beim Menschen. Int J Clin Pharmacol 4 (Suppl):37–41

    Google Scholar 

  • Canepa-Anson R, Dawson JR, Frankl WS, Kuan P, Sutton GC, Reuben S, Poole-Wilson PA (1982) Beta2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias. Eur Heart J 3 (Suppl D):129–134

    PubMed  Google Scholar 

  • Dawson JR, Poole-Wilson PA, Sutton GC (1980) Salbutamol in cardiogenic shock complicating acute myocardial infarction. Br Heart J 43:523–526

    PubMed  Google Scholar 

  • Dawson JR, Bayliss J, Norell MS, Canepa-Anson R, Kuan P, Reuben S, Poole-Wilson PA, Sutton GC (1982) Clinical studies with beta2-adrenoceptor agonists in heart failure. Eur Heart J 3 (Suppl D):135–141

    PubMed  Google Scholar 

  • Gattiker H, Rothlin M (1971) Vergleich der Wirkungen des neuen Sympathicomimeticums Th 1165a mit jenen von Isoprenalin auf den Kreislauf herzoperierter Patienten. Arzneim Forsch 21:1191–1194

    Google Scholar 

  • Heel RC, Brogden RN, Speight TM, Avery GS (1978) Fenoterol: A review of its pharmacological properties and therapeutic efficacy in asthma. Drugs 15:3–32

    PubMed  Google Scholar 

  • Heitz A, Schwartz J, Velly J (1983)β-adrenoceptors of the human myocardium: determination of β1 and β2 subtypes by radioligand binding. Br J Pharmacol 80:711–717

    PubMed  Google Scholar 

  • Irmer M, Wollschläger H, Just H (1981) Behandlung der schweren Herzinsuffizienz mit dem Beta-Stimulator Fenoterol. Klin Wochenschr 59:639–645

    PubMed  Google Scholar 

  • Just H, Drexler H, Irmer M (1983) Therapeutic agents with combined inotropic and vasodilating properties. In: Just H, Bussmann WD (eds) Vasodilators in chronic heart failure, Springer Verlag, Berlin Heidelberg New York, pp 168–175

    Google Scholar 

  • Kerr CR (1979) Hemodynamic effects of oral salbutamol in patients with severe left ventricular failure. Circulation 60 (Suppl II):II-41

    Google Scholar 

  • Lai S, Savidge RS, Davies DM, Ali MM, Soni V (1972) Intravenous salbutamol and cardiogenic shock. Lancet I:853–854

    Google Scholar 

  • Lichtlen P, Stutz R (1969) Hämodynamische Untersuchungen mit dem p-Hydroxyphenylderivat des Orciprenalins. Arzneim Forsch 19:147–149

    Google Scholar 

  • Meinertz T, Nawrath H, Scholz H (1976) Possible role of cyclic AMP in the relaxation process of mammalian heart: Effects of dibutyryl cyclic AMP and theophylline on potassium contractures in cat papillary muscles. Naunyn Schmiedebergs Arch Pharmacol 293:129–137

    PubMed  Google Scholar 

  • Mifune J, Kuramoto K, Ueda K, Matsushita S, Kuwajima I, Sakai M, Iwasaki T, Moroki N, Murakami M (1982) Hemodynamic effects of salbutamol, an oral long-acting beta-stimulant, in patients with congestive heart failure. Am Heart J 104:1011–1015

    PubMed  Google Scholar 

  • Nayler WG, McInnes I (1972) Salbutamol and orciprenaline-induced changes in myocardial function. Cardiovasc Res 6:725–733

    PubMed  Google Scholar 

  • O'Donnell SR (1970) A selectiveβ-adrenoceptor stimulant (Th 1165a) related to orciprenaline. Eur J Pharmacol 12:35–43

    PubMed  Google Scholar 

  • O'Donnell SR, Wanstall JC (1979) The importance of choice of agonist in studies designed to predict β21 adrenoceptor selectivity of antagonists from pA2 values on guinea-pig trachea and atria. Naunyn Schmiedebergs Arch Pharmacol 308:183–190

    PubMed  Google Scholar 

  • O'Donnell SR, Wanstall JC (1980) Evidence that ICI 118551 is a potent, highly beta-2 selective adrenoceptor antagonist and can be used to characterize beta-adrenoceptor populations in tissues. Life Sci 27:671–677

    PubMed  Google Scholar 

  • Poole-Wilson PA, Lewis G, Angerpointer T, Malcolm AD, Williams BT (1977) Haemodynamic effects of salbutamol and nitroprusside after cardiac surgery. Br Heart J 39:721–725

    PubMed  Google Scholar 

  • Robberecht P, Delhaye M, Taton G, De Neef P, Waelbroeck M, De Smet JM, Leclerc JL, Chatelain P, Christophe J (1983) The human heart beta-adrenergic receptors: I. Heterogeneity of the binding sites: Presence of 50% beta1- and 50% beta2-adrenergic receptors. Mol Pharmacol 24:169–173

    PubMed  Google Scholar 

  • Sharma B, Goodwin JF (1978) Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy. Effect on systolic and diastolic function of the left ventricle. Circulation 58:449–460

    PubMed  Google Scholar 

  • Stiles GL, Taylor S, Lefkowitz RJ (1982) Direct indentification of β1 and β2 adrenergic receptors in human left ventricular myocardium. Circulation 66 (Suppl II):II-207

    Google Scholar 

  • Tse TF, Yu D, Wang RYC, Wong P (1978) Effect of berotec in congestive cardiac failure. VIII World Congress of Cardiology, Tokyo, Abstract No. 1269

  • Timmis AD, Strak SK, Chamberlain DA (1979) Haemodynamic effects of salbutamol in patients with acute myocardial infarction and severe left ventricular dysfunction. Br Med J 2:1101–1103

    PubMed  Google Scholar 

  • Waelbroeck M, Taton G, Delhaye M, Chatelain P, Camus JC, Pochet R, Leclerc JL, De Smet JM, Robberecht P, Christophe J (1983) The human heart beta-adrenergic receptors: II. Coupling of beta2-adrenergic receptors with the adenylate cyclase system. Mol Pharmacol 24:174–182

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mügge, A., Posselt, D., Reimer, U. et al. Effects of the beta2-adrenoceptor agonists fenoterol and salbutamol on force of contraction in isolated human ventricular myocardium. Klin Wochenschr 63, 26–31 (1985). https://doi.org/10.1007/BF01537483

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01537483

Key words

Navigation